Berger Financial Group, Inc Edwards Lifesciences Corp Transaction History

Berger Financial Group, Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$84.3 - $94.31 $57,829 - $64,696	-686 Reduced 17.57%	3,219 $297,000
Q1 2024 Apr 16, 2024	SELL	$72.54 - $95.56 $17,337 - $22,838	-239 Reduced 5.77%	3,905 $373,000
Q4 2023 Feb 07, 2024	SELL	$61.71 - $77.76 $41,098 - $51,788	-666 Reduced 13.85%	4,144 $315,000
Q3 2023 Nov 03, 2023	SELL	$69.28 - $93.38 $70,111 - $94,500	-1,012 Reduced 17.38%	4,810 $333,000
Q2 2023 Aug 10, 2023	SELL	$81.41 - $94.33 $7,408 - $8,584	-91 Reduced 1.54%	5,822 $549,000
Q1 2023 Apr 24, 2023	SELL	$74.26 - $84.51 $20,198 - $22,986	-272 Reduced 4.4%	5,913 $489,000
Q4 2022 Jan 30, 2023	SELL	$68.3 - $87.44 $29,095 - $37,249	-426 Reduced 6.44%	6,185 $461,000
Q3 2022 Oct 27, 2022	SELL	$82.37 - $107.29 $30,312 - $39,482	-368 Reduced 5.27%	6,611 $546,000
Q2 2022 Aug 08, 2022	SELL	$86.5 - $128.27 $186,494 - $276,550	-2,156 Reduced 23.6%	6,979 $664,000
Q1 2022 May 10, 2022	BUY	$101.96 - $128.34 $38,540 - $48,512	378 Added 4.32%	9,135 $1.08 Million
Q4 2021 Jan 26, 2022	BUY	$106.37 - $130.68 $931,482 - $1.14 Million	8,757 New	8,757 $1.13 Million

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Berger Financial Group, Inc, based on Form 13F filings with the SEC.

Stay updated on Berger Financial Group, Inc with notifications on news.